Cannabis spray Sativex® launched in Italy for MS spasticity

[MSUK]

Cannabis spray Sativex® launched in Italy for MS spasticity

GW Pharmaceuticals & Almirall S.A. anounced today that Sativex® is now available in Italy as a prescription medicine for use in the treatment of moderate to severe spasticity in Multiple Sclerosis (MS) patients who have not responded adequately to other anti-spasticity medications. The launch follows receipt of full marketing authorization for Sativex® by the Italian health authorities in May. The medicine is reimbursed by the Italian authorities as a Class H (hospital dispensed) medicine. The reimbursed price of the medicine granted by the authorities in Italy is consistent with the reimbursed Sativex® price in Spain............. Read More - http://www.ms-uk.org/index.cfm/sativex